With its ability to enhance predictive accuracy, quantum computing may significantly lower R&D costs in pharmaceuticals by reducing candidate failures.

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...

The unveiling of the Isomorphic Labs Drug Design Engine (IsoDDE) represents a fundamental shift from merely predicting the ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective drug development software offerings with the Indiana-based pharma giant’s ...

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy. A team of ...